ProfileGDS4718 / 202201_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 92% 94% 93% 88% 83% 95% 92% 94% 94% 93% 93% 85% 92% 94% 94% 89% 93% 93% 94% 94% 94% 96% 94% 90% 93% 77% 95% 92% 95% 88% 93% 94% 92% 88% 91% 93% 95% 92% 96% 90% 91% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.304895
GSM549102patient 115, normal, homogenized [OPG study]9.9773894
GSM549104patient 119, normal, homogenized [OPG study]9.5137392
GSM549108patient 138, normal, homogenized [OPG study]10.056394
GSM549119patient 077, normal, homogenized [OPG study]9.7430993
GSM549133patient 032, cancer, homogenized [OPG study]8.9473688
GSM549139patient 042, cancer, homogenized [OPG study]8.2358383
GSM549099patient 107, normal, homogenized [OPG study]10.084895
GSM549109patient 139, normal, homogenized [OPG study]9.6812692
GSM549110patient 046, normal, homogenized [OPG study]10.191894
GSM549114patient 063, normal, homogenized [OPG study]10.142994
GSM549122patient 082, normal, homogenized [OPG study]9.8453293
GSM549134patient 033, cancer, homogenized [OPG study]9.7810493
GSM549136patient 036, cancer, homogenized [OPG study]8.564985
GSM549140patient 044, cancer, homogenized [OPG study]9.6179592
GSM549111patient 047, normal, homogenized [OPG study]10.063194
GSM549113patient 057, normal, homogenized [OPG study]10.130494
GSM549132patient 031, cancer, homogenized [OPG study]9.0427189
GSM549137patient 038, cancer, homogenized [OPG study]9.6670893
GSM549142patient 047, cancer, homogenized [OPG study]9.1983893
GSM549100patient 110, normal, homogenized [OPG study]10.059194
GSM549107patient 135, normal, homogenized [OPG study]10.012894
GSM549115patient 068, normal, homogenized [OPG study]10.196194
GSM549116patient 072, normal, homogenized [OPG study]10.589196
GSM549120patient 078, normal, homogenized [OPG study]10.00994
GSM549131patient 030, cancer, homogenized [OPG study]9.3232590
GSM549118patient 074, normal, homogenized [OPG study]9.8336993
GSM549129patient 027, cancer, homogenized [OPG study]7.5721877
GSM549123patient 088, normal, homogenized [OPG study]10.209295
GSM549124patient 006, cancer, homogenized [OPG study]9.3255792
GSM549126patient 015, cancer, homogenized [OPG study]10.158595
GSM549128patient 025, cancer, homogenized [OPG study]8.9145588
GSM549103patient 117, normal, homogenized [OPG study]9.8024793
GSM549117patient 073, normal, homogenized [OPG study]10.259994
GSM549138patient 041, cancer, homogenized [OPG study]9.6086792
GSM549141patient 045, cancer, homogenized [OPG study]8.9769488
GSM549130patient 028, cancer, homogenized [OPG study]9.2252891
GSM549101patient 111, normal, homogenized [OPG study]9.7802893
GSM549105patient 128, normal, homogenized [OPG study]10.195295
GSM549106patient 134, normal, homogenized [OPG study]9.7618892
GSM549112patient 048, normal, homogenized [OPG study]10.791296
GSM549125patient 011, cancer, homogenized [OPG study]9.1214490
GSM549127patient 024, cancer, homogenized [OPG study]9.2205491
GSM549135patient 035, cancer, homogenized [OPG study]8.5067785